Document Detail


Short-term therapy with celecoxib and lansoprazole modulates Th1/ Th2 immune response in human gastric mucosa.
MedLine Citation:
PMID:  21083751     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: Selective cyclooxygenase-2 (COX-2) inhibitors and proton pump inhibitors may exert immune-mediated effects in human gastric mucosa. T-cell immune response plays a role in Helicobacter pylori-induced pathogenesis. This study evaluated effects of celecoxib and lansoprazole on T-helper (Th) 1 and Th2 immune response in human gastric mucosa.
METHODS: Dyspeptic patients with or without osteoarticular pain were given one of the following 4-week therapies: celecoxib 200 mg, celecoxib 200 mg plus lansoprazole 30 mg, and lansoprazole 30 mg daily. Expression of COX-2, T-bet, and pSTAT6 and production of prostaglandin E₂ (PGE₂), interferon (IFN)-γ, and interleukin (IL)-4 were determined in gastric biopsies before and after therapy. Histology was evaluated.
RESULTS: Cyclooxygenase-2 expression and PGE₂ production was higher, and Th1 signaling pathway was predominant in H. pylori-infected vs. uninfected patients. T-bet expression and IFN-γ production increased, while STAT6 activation and IL-4 production decreased following therapy with celecoxib and celecoxib plus lansoprazole, respectively. Th1 and Th2 signaling pathways down-regulated after therapy with lansoprazole, and this was associated with an improvement of gastritis. Effect of therapy was not affected by H. pylori status.
CONCLUSION: Celecoxib and lansoprazole modulate Th1/Th2 immune response in human gastric mucosa. The use of these drugs may interfere with long-term course of gastritis.
Authors:
Tiziana Larussa; Evelina Suraci; Isabella Leone; Immacolata Nazionale; Ludovico Abenavoli; Olimpio Galasso; Andrea Amorosi; Maria Imeneo; Francesco Luzza
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Helicobacter     Volume:  15     ISSN:  1523-5378     ISO Abbreviation:  Helicobacter     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-11-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9605411     Medline TA:  Helicobacter     Country:  United States    
Other Details:
Languages:  eng     Pagination:  449-59     Citation Subset:  IM    
Copyright Information:
© 2010 Blackwell Publishing Ltd.
Affiliation:
Dipartimento di Medicina Sperimentale e Clinica Dipartimento di Scienze Mediche, Università di Catanzaro "Magna Graecia", Catanzaro, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Helicobacter pylori induction of the gastrin promoter through GC-rich DNA elements.
Next Document:  The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China.